Fist Assist Devices

Fist Assist Devices

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Fist Assist Devices is a private medical technology company targeting the significant clinical and economic challenges in vascular access for hemodialysis. Its core product, the Fist Assist FA-1, is an automated, intermittent pneumatic compression device cleared in the USA as an arm massager to increase circulation, with a primary application in pre-surgical vein dilation and fistula maturation support. The company has completed several clinical studies demonstrating safety and efficacy in vein dilation and positions itself as a cost-reducing solution in the global renal care market, which faces rising patient numbers and high treatment costs. Current commercial activities appear to be managed through a partner, Airos Medical, for US customer service.

NephrologyVascular Access

Technology Platform

Wearable, automated intermittent pneumatic compression (IPC) device that applies cyclic pressure to specific arm veins to induce dilation via mechanical distension and increased wall shear stress.

Opportunities

The global ESRD patient population is growing rapidly, creating a large addressable market.
There is a strong clinical and economic incentive to improve AV fistula success rates to avoid costly and dangerous catheters.
The device's non-invasive, patient-administered nature aligns with trends toward home-based care and patient empowerment.

Risk Factors

Key risks include the challenge of securing specific insurance reimbursement for the device's intended use, potential regulatory scrutiny if marketed off-label for fistula maturation, and the difficulty of changing established clinical practices in a conservative medical specialty.
Competition from other devices or therapies also poses a threat.

Competitive Landscape

Direct competition appears limited, with the primary alternative being manual exercises (e.g., hand-grip). However, the competitive set could include other mechanical vein dilation devices in development, pharmacological therapies aimed at improving vessel health, and advanced surgical techniques. The company's main advantage is its automated, wearable design aimed at solving the compliance problem inherent in manual methods.